Objectives: To review the incidence of healthcare-associated infections/urinary tract infection (UTI), risk factors, microorganisms isolated and antibiotic resistances in patients who underwent lower urinary tract endoscopic surgery (LUTES) in a tertiary care hospital. Methods: A prospective observational study was carried out including 1,498 patients who undergo LUTES. Patients with and without UTI after surgery were compared. We analysed infection incidence, risk factors, microorganisms isolated and antibiotic resistances. Results: Postoperative UTI incidence was 4.7%. Risk factors found: higher American Society of Anesthesiologists classification (OR 2.82; 95% CI 1.8–4.5; p < 0.00), immunosuppression (OR 2.89; 95% CI 1.2–7.2; p = 0.01), indwelling urinary catheter prior admission (OR 2.6; 95% CI 1.6–4.2; p < 0.00) and postoperative catheterization longer than 2 days (OR 1.74; 95% CI 1.7–4.3; p < 0.00). Transurethral resection of the bladder (TURB) had the highest infection rates (5.5%). Microorganisms isolated were Pseudomonas aeruginosa (23.5%), Escherichia coli (17.6%), Klebsiella pneumoniae and Enterococcus spp (11.8%). Resistance rates for flourquinolones varied between 28 and 80%, and Carbapenem-resistant Enterobacteriaceae rose up 20%. Conclusions: Low percentage of UTI after endoscopic surgery was registered. TURB was the procedure with highest infection rate. Pseudomonas aeruginosa stands out as the most frequently isolated microorganism. Patient comorbidities, previous urinary catheter and postoperative catheter were identified as risk factors.

Keywords:
Antibiotic resistance, Endoscopic surgery, Healthcare-associated infection, Urinary tract infection
1.
Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309–332.
2.
Bjerklund Johansen TE, Cek M, Naber K, et al; PEP and PEAP study investigators; European Society of Infections in Urology: Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 2007; 51: 1100–1111.
3.
Junuzovic D, Hasanbegovic M, Zvizdic S, et al: The connection between endourological procedures and occurrence of urinary infections. Mater Sociomed 2014; 26: 237–241.
4.
Junuzovic D, Hasanbegovic M: Risk Factors analysis for occurrence of asymptomatic bacteriuria after endourological procedures. Med Arch 2014; 68: 249–253.
5.
Johansen TE, Botto H, Cek M, et al: Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents 2011; 38: 64–70.
6.
Grave M, Bartoletti R, Bjerklund-Johansen TE, Cai T, et al: Guidelines on Urological Infections. European Association of Urology. 2017. www.uroweb.org/guidelines/online-guidelines
7.
Wagenlehner F, Tandogdu Z, Bartoletti R, et al: The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 2016; 5: pii:E10.
8.
Tandogdu Z, Wagenlehner FM: Global epidemiology of urinary tract infections. Curr Opin Infect Dis 2016; 29: 73–79.
9.
Yamamoto S, Shigemura K, Kiyota H, et al; Japanese Research Group for UTI: Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition. Int J Urol 2016; 23: 814–824.
10.
Osman T, ElSaeed KO, Youssef HA, et al: Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria. Arab J Urol 2017; 15: 260–266.
11.
Hooton TM, Bradley SF, Cardenas DD, et al: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis 2010; 50: 625–663.
12.
El Basri A, Petrolekas A, Cariou G, et al: Clinical significance of routine urinary bacterial culture after transurethral surgery: results of a prospective multicenter study. Urology 2012; 79: 564–569.
13.
Traxer O, Pasqui F, Gattegno B, et al: Technique and complications of transurethral surgery for bladder tumours. BJU Int 2004; 94: 492–496.
14.
Dick A, Barnes R, Hadley H, et al: Complications of transurethral resection of bladder tumors: prevention, recognition and treatment. J Urol1980; 124: 810–821.
15.
Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015; 67: 1099–1109.
16.
Reich O, Gratzke C, Bachmann A, et al: Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246–249.
17.
Palaniappan S, Kuo TL, Cheng CW, et al: Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singapore Med J 2016; 57: 676–680.
18.
Shah HN, Mahajan AP, Hegde SS, et al: Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 2007; 100: 94–101.
19.
Li S, Zeng XT, Ruan XL, et al: Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis. PLoS One 2014; 9:e101615.
20.
Bouassida K, Jaidane M, Bouallegue O, et al: Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control. Can Urol Assoc J 2016; 10:E87–E93.
21.
Tandogdu Z, Cek M, Wagenlehner F, et al: Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol 2014; 32: 791–801.
22.
Medina-Polo J, Sopeña-Sutil R, Benítez-Sala R, et al: Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a urology ward. Investig Clin Urol 2017; 58: 61–69.
23.
Rosselló-Urgell J, Vaqué-Rafart J, Hermosilla-Pérez E, et al; EPINE Working Group: An approach to the study of potentially preventable nosocomial infections. Infect Control Hosp Epidemiol 2004; 25: 41–46.
24.
Concia E, Azzini AM: Aetiology and antibiotic resistance issues regarding urological procedures. J Chemother 2014; 26:S14–S23.
25.
Centers for Disease Control and Prevention. Healthcare-Associated Infections. Atlanta, Centers for Disease Control and Prevention, 2016. https://www.cdc.gov/hai/ (cited November 9, 2016).
26.
Alsaywid BS, Smith GH: Antibiotic prophylaxis for transurethral urological surgeries: Systematic review. Urol Ann 2013; 5: 61–74.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.